跳至主要内容
临床试验/NCT01593267
NCT01593267Unknown不适用

Barrow Ruptured Aneurysm Study

St. Joseph's Hospital and Medical Center, Phoenix2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2002年11月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
2
主要终点
Modified Rankin Scale

研究概览

简要总结

With evolving endovascular technologies there is a growing debate centered on the relative safety and efficacy of the currently accepted alternatives for the treatment of ruptured cerebral aneurysms in the face of acute subarachnoid hemorrhage (SAH). The purpose of this study is to compare the safety and efficacy of microsurgical clipping and endovascular coiling of acutely ruptured cerebral aneurysms in a prospective, randomized fashion.

详细描述

The planned trial enrolled 250 subjects per arm. Subjects are followed postoperatively and outcome endpoints will be assessed at Discharge, 6 Months, 1 Year, 3 Years, and 6 Years. One hundred (100) subjects will participate in neuropsychological testing at 1 Year; after the 100th subject an interim data analysis will be performed and the viability of future neuropsychological testing will be determined. Subjects will receive preoperative, intraoperative or postoperative, 3 Year follow up, and 6 Year follow up angiograms. In this fashion immediate clinical outcome, including peri-procedural morbidity and mortality, will be assessed as will long term outcome, both clinical and angiographic.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute subarachnoid hemorrhage (SAH)
  • Confirmed by CT scan or lumbar puncture
  • Age 18-80 years
  • Ability to give informed consent (subject or legally authorized representative)
  • No anatomic inclusions

排除标准

  • Traumatic subarachnoid hemorrhage
  • Presents to hospital >14 days post-bleed
  • SAH caused by other primary disease
  • No anatomic exclusions

结局指标

主要结局

Modified Rankin Scale

时间窗: 10 years

Primary Outcome Measure is Modified Rankin Scale \< or = to 2. Data will be analyzed on intent to treat basis with crossover to the alternative treatment analyzed as a data subset. The null hypothesis is that no difference in outcome will be detected between the endovascular and surgical treatment arms. A statistically significant difference will then be considered evidence in favor of the alternative hypothesis, that one treatment is superior to the other.

次要结局

未报告次要终点

研究者

发起方
St. Joseph's Hospital and Medical Center, Phoenix
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lisa Arnold

Research Operations Manager

St. Joseph's Hospital and Medical Center, Phoenix

研究点 (2)

Loading locations...

相似试验

Barrow Ruptured Aneurysm Trial | 临床试验